Blog

Dual-Action Anti-Obesity Strategy: Small-Molecule CNOT6L Inhibitor YL-333P Simultaneously Drives Appetite Suppression and Energy Expenditure

September 16, 2026

Beyond Body Mass Index: How the OBSCORE Framework Enables Precision Prioritization for Weight Loss Interventions

September 16, 2026

Engineering Next-Generation Multispecifics: Discovery of AMG 133 as a First-in-Class GIPR Antagonist and GLP-1R Agonist Conjugate for Obesity

September 16, 2026

Comparative Efficacy of Traditional Chinese Medicine Non-Pharmacological Interventions for Simple Obesity: A Network Meta-Analysis

September 16, 2026

Reprogramming the Metabolome: How Antibiotic Exposure Drives Obesity and Metabolic Phenotypes via Gut Microbiota Dysbiosis

September 16, 2026

Beyond the Gut: How Early Postnatal Antibiotic Exposure Programs Brown Adipose Tissue and Adult Lipid Metabolism

September 16, 2026

Can Genetic Risk Disclosure Drive Real Weight Loss? Insights from an 18-Month Randomized Controlled Trial

September 16, 2026

Mapping the Genomic Architecture of Obesity: Frequency Landscape of Six Metabolic Variants in Mexico City

September 16, 2026

Beyond More Stimulation: Why Cellular Competence Dictates the Success of Thermogenic Therapies

June 22, 2026

Beyond the Scale: Redefining Success in Modern Evidence-Based Obesity Care

June 22, 2026